Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
26m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
26m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
26m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
27m agoFirst Quantum Minerals Reports First Quarter 2026 Results
27m agoDistrict Metals Announces $10 Million Private Placement Financing
Sionna Therapeutics, Inc. Common Stock logo

Sionna Therapeutics, Inc. Common Stock

About

Sionna Therapeutics, Inc. Common Stock (NASDAQ:SION) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 27 2026
Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis
Apr 7 2026
Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium
Mar 2 2026
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 23 2026
Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences
Feb 4 2026
Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026

Financials

Revenue
$0
Market Cap
$1.82 B
EPS
-1.88

Community Chat

Ask AI

6ix6ixAIEvents